β-Arrestins are a class of proteins that play a crucial role in the regulation of G-protein coupled receptors (GPCRs). GPCRs are a large family of receptors that detect molecules outside the cell and activate internal signaling pathways in response. They are involved in a myriad of physiological processes and are the targets of a significant portion of modern medicines. Among the β-arrestins, β-arrestin-2 stands out for its specific regulatory functions. When a GPCR is activated by its ligand, β-arrestin-2 is recruited to the receptor, leading to receptor desensitization, internalization, and sometimes initiating separate signaling cascades independent of G-proteins.
β-Arrestin-2 inhibitors are molecules specifically designed to impede the activity or interaction of β-arrestin-2 with GPCRs or other associated proteins. By inhibiting β-arrestin-2, these compounds can modulate the desensitization and internalization of GPCRs, altering the duration and intensity of receptor signaling. Furthermore, since β-arrestin-2 can initiate its own signaling pathways, independent of G-proteins, its inhibitors can also influence these β-arrestin-2-mediated pathways. The exact mechanisms by which these inhibitors operate can vary. Some might prevent the binding of β-arrestin-2 to GPCRs, while others might disrupt its interaction with other intracellular signaling proteins.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Compound 101 | 161125-36-6 | sc-507528 | 5 mg | $108.00 | ||
GRK2 phosphorylates activated GPCRs, facilitating β-arrestin binding. By inhibiting GRK2, one might indirectly impact β-Arrestin-2 levels. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Losartan, an angiotensin II receptor antagonist, might affect β-Arrestin-2-associated pathways, potentially influencing its expression. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is a Src family kinase inhibitor, and since Src kinases can modulate β-arrestin signaling, PP2 might indirectly down-regulate β-Arrestin-2. | ||||||
Clozapine | 5786-21-0 | sc-200402 sc-200402A sc-200402B sc-200402C | 50 mg 500 mg 5 g 10 g | $69.00 $364.00 $2500.00 $4100.00 | 11 | |
Clozapine can modulate various GPCR pathways, potentially influencing β-Arrestin-2 levels. | ||||||
Ebselen | 60940-34-3 | sc-200740B sc-200740 sc-200740A | 1 mg 25 mg 100 mg | $33.00 $136.00 $458.00 | 5 | |
Ebselen has antioxidant properties and might affect various signaling pathways, potentially influencing β-Arrestin-2 expression. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
As a GSK-3 inhibitor, SB-216763 may have indirect effects on pathways involving β-Arrestin-2, potentially down-regulating it. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD-98059, a MEK inhibitor, may modulate pathways that involve β-Arrestin-2, potentially influencing its expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG-132 inhibits the proteasome and could influence the degradation of β-Arrestin-2, though it might have a complex role. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine affects endosomal-lysosomal activity, which could have indirect effects on β-Arrestin-2 trafficking and expression. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore inhibits dynamin, affecting endocytosis. This could indirectly influence the activity and levels of β-Arrestin-2. | ||||||